![](/img/cover-not-exists.png)
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers
Jhaveri, Komal, Chang, Matthew T, Juric, Dejan, Saura, Cristina, Gambardella, Valentina, Melnyk, Anton, Patel, Manish R., Ribrag, Vincent, Ma, Cynthia X., Aljumaily, Raid, Bedard, Philippe L., SachdevJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-2657
Date:
November, 2020
File:
PDF, 1.69 MB
2020